DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
130.02
-0.78 (-0.60%)
Sep 29, 2025, 3:17 PM EDT - Market open
DaVita Revenue
DaVita had revenue of $3.38B in the quarter ending June 30, 2025, with 6.05% growth. This brings the company's revenue in the last twelve months to $13.16B, up 5.09% year-over-year. In the year 2024, DaVita had annual revenue of $12.82B with 5.56% growth.
Revenue (ttm)
$13.16B
Revenue Growth
+5.09%
P/S Ratio
0.80
Revenue / Employee
$173,175
Employees
76,000
Market Cap
9.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.82B | 675.40M | 5.56% |
| Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
| Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
| Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
| Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DVA News
- 4 weeks ago - DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care - PRNewsWire
- 5 weeks ago - Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows - Reuters
- 5 weeks ago - DaVita: Aggressive Buybacks Despite Rising Cost Of Debt - Seeking Alpha
- 7 weeks ago - DaVita Inc. (DVA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - DaVita beats quarterly profit on steady demand for dialysis services - Reuters
- 7 weeks ago - DaVita Inc. 2nd Quarter 2025 Results - PRNewsWire
- 2 months ago - DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call - PRNewsWire
- 4 months ago - 20 stocks primed for rapid growth while trading at half of Nvidia's valuation - Market Watch